These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 18217912)
1. Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients. Martin JE; Cavanaugh TM; Trumbull L; Bass M; Weber F; Aranda-Michel J; Hanaway M; Rudich S Clin Transplant; 2008; 22(1):113-9. PubMed ID: 18217912 [TBL] [Abstract][Full Text] [Related]
2. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients. Nichols GA; Koro CE Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557 [TBL] [Abstract][Full Text] [Related]
6. Low myopathy rates associated with statins as monotherapy or combination therapy with interacting drugs in a group model health maintenance organization. Shanahan RL; Kerzee JA; Sandhoff BG; Carroll NM; Merenich JA Pharmacotherapy; 2005 Mar; 25(3):345-51. PubMed ID: 15843281 [TBL] [Abstract][Full Text] [Related]
7. [Rhabdomyolysis in patients treated with simvastatin and cyclosporin: role of the hepatic cytochrome P450 enzyme system activity]. Meier C; Stey C; Brack T; Maggiorini M; Risti B; Krähenbühl S Schweiz Med Wochenschr; 1995 Jul; 125(27-28):1342-6. PubMed ID: 7624744 [TBL] [Abstract][Full Text] [Related]
8. Asymptomatic statin-induced rhabdomyolysis after long-term therapy with the hydrophilic drug pravastatin. Schindler C; Thorns M; Matschke K; Tugtekin SM; Kirch W Clin Ther; 2007 Jan; 29(1):172-6. PubMed ID: 17379057 [TBL] [Abstract][Full Text] [Related]
9. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis. Koro CE; Sowell MO; Stender M; Qizilbash N Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of statin therapy in patients switched from cyclosporine a to sirolimus after cardiac transplantation. Aliabadi AZ; Mahr S; Dunkler D; Grömmer M; Zimpfer D; Wolner E; Grimm M; Zuckermann AO Transplantation; 2008 Dec; 86(12):1771-6. PubMed ID: 19104420 [TBL] [Abstract][Full Text] [Related]
11. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin. Jones PH; Davidson MH Am J Cardiol; 2005 Jan; 95(1):120-2. PubMed ID: 15619408 [TBL] [Abstract][Full Text] [Related]
12. Use of a tiered review for evaluation of appropriate use of hydroxymethylglutaryl coenzyme A reductase-inhibitor therapy. Strauss WE; Alexis G; Tapley RD Clin Ther; 1999 Feb; 21(2):422-9. PubMed ID: 10211542 [TBL] [Abstract][Full Text] [Related]
13. [Rhabdomyolysis and acute renal failure secondary to statins]. Borrego FJ; Liébana A; Borrego J; Pérez del Barrio P; Gil JM; García Cortés MJ; Sánchez Perales C; Serrano P; Pérez Bañasco V Nefrologia; 2001; 21(3):309-13. PubMed ID: 11471312 [TBL] [Abstract][Full Text] [Related]
14. Acute myopathy in a patient with concomitant use of pravastatin and colchicine. Alayli G; Cengiz K; Cantürk F; Durmuş D; Akyol Y; Menekşe EB Ann Pharmacother; 2005; 39(7-8):1358-61. PubMed ID: 15914514 [TBL] [Abstract][Full Text] [Related]
15. Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia. Almutairi F; Peterson TC; Molinari M; Walsh MJ; Alwayn I; Peltekian KM Liver Transpl; 2009 May; 15(5):504-8. PubMed ID: 19399742 [TBL] [Abstract][Full Text] [Related]
16. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy. Fazio S Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268 [TBL] [Abstract][Full Text] [Related]
18. Rhabdomyolysis in association with simvastatin and amiodarone. Roten L; Schoenenberger RA; Krähenbühl S; Schlienger RG Ann Pharmacother; 2004 Jun; 38(6):978-81. PubMed ID: 15069169 [TBL] [Abstract][Full Text] [Related]
19. Statin safety and drug interactions: clinical implications. Bottorff MB Am J Cardiol; 2006 Apr; 97(8A):27C-31C. PubMed ID: 16581325 [TBL] [Abstract][Full Text] [Related]
20. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil]. Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]